![](/img/cover-not-exists.png)
Prognostic and predictive value ofTP53mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial
Lynnette Fernández-Cuesta, Catherine Oakman, Priscila Falagan-Lotsch, Ke-seay Smoth, Emmanuel Quinaux, Marc Buyse, M Stella Dolci, Evandro De Azambuja, Pierre Hainaut, Patrizia Dell’Orto, Denis LarsimVolume:
14
Language:
english
DOI:
10.1186/bcr3179
Date:
June, 2012
File:
PDF, 307 KB
english, 2012